Organoid
10
5
5
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (10)
Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatment
Drug Response Testing and Repurposing Using Glioblastoma Organoid
Observation of Clinical Consistency of Organoid-chips Drug Sensitivity in Chemotherapy for PCa With Visceral Metastasis
Patient-derived Organoids of Lung Cancer to Test Drug Response
Organoids Predict Therapeutic Response in Patients With Multi-line Drug-resistant Lung Cancer
Gastric Cancer Organoids in the Screening of Neoadjuvant Drugs
Construction of Gynecological Tumor Organoids
Organoid Based Response Prediction in Esophageal Cancer
Study on the Consistency Evaluation of Organoids Used in the Clinical Treatment of Ovarian Cancer With Anti-tumor Drugs
Clinical Study on Drug Sensitivity Verification or Prediction of Therapy for Breast Cancer by Patient-Derived Organoid Model